Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System

Gastrointestinal perforations have been reported in a small number of rheumatoid arthritis (RA) patients treated with Janus kinase (JAK) inhibitors in clinical trials. However, large-scale postmarketing data repositories are needed to further investigate this potentially rare but serious adverse eve...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	United European gastroenterology journal 2024-12
Hauptverfasser:	Goldman, Adam, Raschi, Emanuel, Druyan, Amit, Sharif, Kassem, Lahat, Adi, Ben-Zvi, Ilan, Ben-Horin, Shomron
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!